BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7572424)

  • 1. Suppression of experimental glomerulonephritis by interference with T- or B-cell activation signals or adhesion molecules.
    Andres G; Nishikawa K; Stamenkovic I; McCluskey RT
    Adv Nephrol Necker Hosp; 1995; 24():91-105. PubMed ID: 7572424
    [No Abstract]   [Full Text] [Related]  

  • 2. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD28 costimulatory pathway.
    Leung HT; Linsley PS
    Ther Immunol; 1994 Aug; 1(4):217-28. PubMed ID: 7584497
    [No Abstract]   [Full Text] [Related]  

  • 4. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
    Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
    Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 functions as an adhesion molecule and is involved in the regulation of human IgE synthesis.
    Life P; Aubry JP; Estoppey S; Schnuriger V; Bonnefoy JY
    Eur J Immunol; 1995 Feb; 25(2):333-9. PubMed ID: 7533083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated T cells can induce high levels of CTLA-4 expression on B cells.
    Kuiper HM; Brouwer M; Linsley PS; van Lier RA
    J Immunol; 1995 Aug; 155(4):1776-83. PubMed ID: 7543532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD28/CTLA-4:B7 receptor system in experimental autoimmune encephalomyelitis.
    Linsley PS
    J Clin Invest; 1995 Jun; 95(6):2429-30. PubMed ID: 7539451
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
    Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
    J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
    Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B7/CD28/CTLA4 T-cell activation pathway. Implications for inflammatory lung disease.
    Green JM
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):261-4. PubMed ID: 10696061
    [No Abstract]   [Full Text] [Related]  

  • 14. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
    Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
    J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
    Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
    J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell regulation by CD28 and CTLA-4.
    Alegre ML; Frauwirth KA; Thompson CB
    Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-specific therapy in autoimmune glomerulonephritis.
    Nikolic-Paterson DJ
    Am J Kidney Dis; 2001 Dec; 38(6):1321-8. PubMed ID: 11728969
    [No Abstract]   [Full Text] [Related]  

  • 20. An inhibitor of CD28-CD80 interactions impairs CD28-mediated costimulation of human CD4 T cells.
    Fine JS; Macosko HD; Justice L; Chou CC; Jenh CH; Narula SK; Zavodny PJ
    Cell Immunol; 1999 Jan; 191(1):49-59. PubMed ID: 9918686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.